造血集落刺激因子使用建议更新：循证临床实践指南。美国临床肿瘤学会。 - Suppr

Suppr

超能文献

Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines. American Society of Clinical Oncology.

出版信息

J Clin Oncol. 1996 Jun;14(6):1957-60. doi: 10.1200/JCO.1996.14.6.1957.

DOI:10.1200/JCO.1996.14.6.1957

PMID:8656266

Abstract

摘要

相似文献

Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines. American Society of Clinical Oncology.造血集落刺激因子使用建议更新：循证临床实践指南。美国临床肿瘤学会。

J Clin Oncol. 1996 Jun;14(6):1957-60. doi: 10.1200/JCO.1996.14.6.1957.

1997 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology.造血集落刺激因子使用建议的1997年更新：循证临床实践指南。美国临床肿瘤学会。

J Clin Oncol. 1997 Oct;15(10):3288. doi: 10.1200/JCO.1997.15.10.3288.

2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel.造血集落刺激因子使用建议的2000年更新：循证临床实践指南。美国临床肿瘤学会生长因子专家小组。

J Clin Oncol. 2000 Oct 15;18(20):3558-85. doi: 10.1200/JCO.2000.18.20.3558.

American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines.美国临床肿瘤学会。造血集落刺激因子使用建议：循证临床实践指南。

J Clin Oncol. 1994 Nov;12(11):2471-508. doi: 10.1200/JCO.1994.12.11.2471.

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.白细胞生长因子使用建议的2006年更新：基于证据的临床实践指南

J Clin Oncol. 2006 Jul 1;24(19):3187-205. doi: 10.1200/JCO.2006.06.4451. Epub 2006 May 8.

Impact of American Society of Clinical Oncology guidelines for clinical use of colony-stimulating factors.

J Clin Oncol. 1999 Oct;17(10):3360-1. doi: 10.1200/JCO.1999.17.10.3360.

Clinical investigators discuss colony-stimulating factors.临床研究人员讨论集落刺激因子。

Oncology (Williston Park). 1991 Aug;5(8):138-44.

The use of myeloid colony-stimulating factors in hematologic malignancies: the role of systematic reviews and meta-analyses.髓系集落刺激因子在血液系统恶性肿瘤中的应用：系统评价和荟萃分析的作用。

Acta Haematol. 2011;125(1-2):68-79. doi: 10.1159/000318898. Epub 2010 Dec 8.

The relationship between introduction of American society of clinical oncology guidelines and the use of colony-stimulating factors in clinical practice in a Paris university hospital.美国临床肿瘤学会指南的引入与巴黎一家大学医院临床实践中集落刺激因子使用之间的关系。

Clin Ther. 2001 Jul;23(7):1116-27. doi: 10.1016/s0149-2918(01)80095-3.

Use of hematopoietic colony-stimulating factors: the American Society of Clinical Oncology survey. The Health Services Research Committee of the American Society of Clinical Oncology.造血集落刺激因子的使用：美国临床肿瘤学会调查。美国临床肿瘤学会卫生服务研究委员会。

J Clin Oncol. 1996 Sep;14(9):2511-20. doi: 10.1200/JCO.1996.14.9.2511.

引用本文的文献

Differential role of segments of α-mating factor secretion signal in Pichia pastoris towards granulocyte colony-stimulating factor emerging from a wild type or codon optimized copy of the gene.α-交配因子分泌信号片段在毕赤酵母中对粒细胞集落刺激因子的不同作用，该信号来自野生型或基因密码子优化拷贝。

Microb Cell Fact. 2020 Oct 29;19(1):199. doi: 10.1186/s12934-020-01460-8.

Flt3L Treatment of Bone Marrow Donors Increases Graft Plasmacytoid Dendritic Cell Content and Improves Allogeneic Transplantation Outcomes.Flt3L 治疗骨髓供者可增加移植物浆细胞样树突状细胞含量并改善同种异体移植结局。

Biol Blood Marrow Transplant. 2019 Jun;25(6):1075-1084. doi: 10.1016/j.bbmt.2018.11.029. Epub 2018 Nov 29.

Patterns of growth factor usage and febrile neutropenia among older patients with diffuse large B-cell non-Hodgkin lymphoma treated with CHOP or R-CHOP: the Intergroup experience (CALGB 9793; ECOG-SWOG 4494).接受CHOP或R-CHOP治疗的老年弥漫性大B细胞非霍奇金淋巴瘤患者生长因子使用模式及发热性中性粒细胞减少症：多中心研究经验（CALGB 9793；ECOG-SWOG 4494）

Leuk Lymphoma. 2017 Aug;58(8):1814-1822. doi: 10.1080/10428194.2016.1265111. Epub 2016 Dec 14.

Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials.替泊苷对软组织肉瘤患者是一种可行的治疗方法，与患者年龄无关：五项 II 期临床试验的回顾性汇总分析。

Br J Cancer. 2013 Oct 1;109(7):1717-24. doi: 10.1038/bjc.2013.524. Epub 2013 Sep 10.

Trabectedin as single agent in relapsed advanced ovarian cancer: results from a retrospective pooled analysis of three phase II trials.曲贝替定单药治疗复发性晚期卵巢癌：三项 II 期临床试验回顾性 pooled 分析结果。

Med Oncol. 2013 Mar;30(1):435. doi: 10.1007/s12032-012-0435-1. Epub 2013 Feb 9.

Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.用于预防恶性淋巴瘤治疗中不良反应的粒细胞生成刺激因子。

Cochrane Database Syst Rev. 2008 Oct 8;2008(4):CD003189. doi: 10.1002/14651858.CD003189.pub4.

Concurrent doxorubicin plus docetaxel is not more effective than concurrent doxorubicin plus cyclophosphamide in operable breast cancer with 0 to 3 positive axillary nodes: North American Breast Cancer Intergroup Trial E 2197.对于腋窝淋巴结0至3个阳性的可手术乳腺癌患者，多柔比星联合多西他赛与多柔比星联合环磷酰胺相比并无更高疗效：北美乳腺癌协作组试验E 2197。

J Clin Oncol. 2008 Sep 1;26(25):4092-9. doi: 10.1200/JCO.2008.16.7841. Epub 2008 Aug 4.

Low-dose granulocyte colony-stimulating factor overcomes neutropenia in the treatment of non-Hodgkin's lymphoma with higher cost-effectiveness.低剂量粒细胞集落刺激因子在治疗非霍奇金淋巴瘤时可克服中性粒细胞减少症，且具有更高的成本效益。

Int J Hematol. 2005 Dec;82(5):430-6. doi: 10.1532/IJH97.05001.

Granulocyte colony--stimulating factor for chemotherapy-induced neutropenia in patients with small cell lung cancer : the 40% rule revisited.粒细胞集落刺激因子用于小细胞肺癌患者化疗所致中性粒细胞减少症：重新审视40%规则

Pharmacoeconomics. 2005;23(8):767-75. doi: 10.2165/00019053-200523080-00003.

Dependence of positive effects of granulocyte colony-stimulating factor on the antibiotic regimen: evaluation in rats with polymicrobial peritonitis.粒细胞集落刺激因子的积极作用对抗生素治疗方案的依赖性：在多微生物性腹膜炎大鼠中的评估

World J Surg. 2004 Aug;28(8):834-44. doi: 10.1007/s00268-004-7210-1. Epub 2004 Aug 3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验